EA Series Trust’s CVS Health CVS Stock Holding History

EA Series Trust’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$819K	Buy	+11,850	New	+$843K	0.03%	671

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

EA Series Trust's CVS Position: Q2 2023 in Review

EA Series Trust opened a new position in CVS Health (CVS) in Q2 2023: 11,850 shares worth $819K. The stake represents 0.03% of the portfolio and ranks #671 among its holdings.

2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

EA Series Trust held 11,850 shares of CVS Health worth $819K as of Q2 2023.
CVS Health was a new EA Series Trust position in Q2 2023.
CVS Health made up 0.03% of EA Series Trust's portfolio in Q2 2023, its #671 holding.
2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.